26322922 32302706 26458404 30216732 33670126 27367913 33016313 35199858 33063820 35033621 32550040 34359922 32321734 32708755 24390175 31427727 25666042 32719672 31506648 24446061 26304699 35688180 33443816 34712133 23504361 33946649 34607005 2963669 - Search Results

Year	Number of Results
2013	3
2014	13
2015	13
2016	12
2017	3
2018	12
2019	5
2020	26
2021	25
2022	9

1

ACE2 and Microbiota: Emerging Targets for Cardiopulmonary Disease Therapy.

Cole-Jeffrey CT, Liu M, Katovich MJ, Raizada MK, Shenoy V. Cole-Jeffrey CT, et al. J Cardiovasc Pharmacol. 2015 Dec;66(6):540-50. doi: 10.1097/FJC.0000000000000307. J Cardiovasc Pharmacol. 2015. PMID: 26322922 Free PMC article. Review.

2

Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor.

Li Y, Zhou W, Yang L, You R. Li Y, et al. Pharmacol Res. 2020 Jul;157:104833. doi: 10.1016/j.phrs.2020.104833. Epub 2020 Apr 14. Pharmacol Res. 2020. PMID: 32302706 Free PMC article. Review.

3

Anti-hypertensive Effects of Diminazene Aceturate: An Angiotensin- Converting Enzyme 2 Activator in Rats.

De Maria ML, Araújo LD, Fraga-Silva RA, Pereira LA, Ribeiro HJ, Menezes GB, Shenoy V, Raizada MK, Ferreira AJ. De Maria ML, et al. Protein Pept Lett. 2016;23(1):9-16. doi: 10.2174/0929866522666151013130550. Protein Pept Lett. 2016. PMID: 26458404

4

New and Emerging Therapies for Pulmonary Arterial Hypertension.

Spiekerkoetter E, Kawut SM, de Jesus Perez VA. Spiekerkoetter E, et al. Annu Rev Med. 2019 Jan 27;70:45-59. doi: 10.1146/annurev-med-041717-085955. Epub 2018 Sep 14. Annu Rev Med. 2019. PMID: 30216732 Free PMC article. Review.

5

Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options.

Rajapaksha IG, Gunarathne LS, Angus PW, Herath CB. Rajapaksha IG, et al. J Clin Med. 2021 Feb 11;10(4):702. doi: 10.3390/jcm10040702. J Clin Med. 2021. PMID: 33670126 Free PMC article. Review.

6

Angiotensin converting enzyme 2 and diminazene: role in cardiovascular and blood pressure regulation.

Velkoska E, Patel SK, Burrell LM. Velkoska E, et al. Curr Opin Nephrol Hypertens. 2016 Sep;25(5):384-95. doi: 10.1097/MNH.0000000000000254. Curr Opin Nephrol Hypertens. 2016. PMID: 27367913 Review.

7

Brain angiotensin converting enzyme-2 in central cardiovascular regulation.

Mohammed M, Berdasco C, Lazartigues E. Mohammed M, et al. Clin Sci (Lond). 2020 Oct 16;134(19):2535-2547. doi: 10.1042/CS20200483. Clin Sci (Lond). 2020. PMID: 33016313 Free PMC article. Review.

8

Challenges with the proposed ACE2 activation mechanism of diminazene aceturate.

Esfahani SH, Karamyan VT. Esfahani SH, et al. Clin Exp Pharmacol Physiol. 2022 May;49(5):608-610. doi: 10.1111/1440-1681.13636. Epub 2022 Feb 24. Clin Exp Pharmacol Physiol. 2022. PMID: 35199858 No abstract available.

9

ACE2 as therapeutic agent.

Li Q, Grant MB, Richards EM, Raizada MK. Li Q, et al. Clin Sci (Lond). 2020 Oct 16;134(19):2581-2595. doi: 10.1042/CS20200570. Clin Sci (Lond). 2020. PMID: 33063820 Review.

10

Diminazene Aceturate, an angiotensin converting enzyme 2 (ACE2) activator, promotes cardioprotection in ischemia/reperfusion-induced cardiac injury.

Coutinho DCO, Santos-Miranda A, Joviano-Santos JV, Foureaux G, Santos A, Rodrigues-Ferreira C, Martins-Júnior PA, Resende RR, Medei E, Vieyra A, Santos RAS, Cruz JS, Ferreira AJ. Coutinho DCO, et al. Peptides. 2022 May;151:170746. doi: 10.1016/j.peptides.2022.170746. Epub 2022 Jan 13. Peptides. 2022. PMID: 35033621 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results